Format
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 5

1.

Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering.

Novitsky V, Zahralban-Steele M, McLane MF, Moyo S, van Widenfelt E, Gaseitsiwe S, Makhema J, Essex M.

J Clin Microbiol. 2015 Aug;53(8):2581-92. doi: 10.1128/JCM.00756-15. Epub 2015 Jun 3. Erratum in: J Clin Microbiol. 2016 Apr;54(4):1175.

2.

Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.

Fogel J, Hoover DR, Sun J, Mofenson LM, Fowler MG, Taylor AW, Kumwenda N, Taha TE, Eshleman SH.

AIDS. 2011 Apr 24;25(7):911-7. doi: 10.1097/QAD.0b013e328344fedc.

3.

Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.

Persaud D, Bedri A, Ziemniak C, Moorthy A, Gudetta B, Abashawl A, Mengistu Y, Omer SB, Isehak A, Kumbi S, Adamu R, Lulseged S, Ashworth R, Hassen E, Ruff A; Ethiopian Swen Study Team.

AIDS Res Hum Retroviruses. 2011 Aug;27(8):823-9. doi: 10.1089/AID.2010.0346. Epub 2011 Feb 25.

4.

Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda.

Towler WI, Barlow-Mosha L, Church JD, Bagenda D, Ajuna P, Mubiru M, Musoke P, Eshleman SH.

AIDS Res Hum Retroviruses. 2010 May;26(5):563-8. doi: 10.1089/aid.2009.0164.

5.

Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero.

Lidström J, Li Q, Hoover DR, Kafulafula G, Mofenson LM, Fowler MG, Thigpen MC, Kumwenda N, Taha TE, Eshleman SH.

AIDS. 2010 Jan 28;24(3):381-6. doi: 10.1097/QAD.0b013e3283352ef1.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk